In-Session Involvement in Anxious Youth Receiving CBT with/without Medication
- PDF / 406,920 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 63 Downloads / 138 Views
In-Session Involvement in Anxious Youth Receiving CBT with/without Medication Erika A. Chiappini 1 & Elizabeth Gosch 2 & Scott N. Compton 3 & Thomas M. Olino 4 & Boris Birmaher 5 & Dara Sakolsky 5 & Tara S. Peris 6 & John Piacentini 6 & Anne Marie Albano 7 & Courtney P. Keeton 8 & John T. Walkup 9 & Golda Ginsburg 10 & Philip C. Kendall 4
# Springer Science+Business Media, LLC, part of Springer Nature 2020
Abstract Although in-session factors of CBT for youth anxiety (e.g., youth involvement; therapist behaviors) have demonstrated significant associations with treatment outcomes, no study has examined the role of concurrent selective-serotonin reuptake inhibitors (SSRI) on in-session behavior affecting youth outcomes. The combination of SSRI and CBT have demonstrated robust outcomes over either treatment alone. Research has also neglected to examine in-session behavior based on treatment phase (i.e., psychoeducation, exposure) and the association between in-session factors and treatment outcome. Youth (N = 190) were participants in the Children/Adolescent Anxiety Multimodal Study (Walkup et al. New England Journal of Medicine, 359, 2753-2766, 2008) who completed CBT; of these, n = 94 received concurrent sertraline. Tapes of psychoeducation/skillbuilding (first half) and exposure sessions (second half) were rated by reliable coders for positive youth involvement (e.g., participation, understanding), negative youth involvement (e.g., safety-behaviors, negative affect), and therapist behaviors. Youth and therapist in-session behaviors were examined as predictors of the trajectory of anxiety outcomes using multilevel modeling. Medication (sertraline) was examined as a moderator. Results indicated that positive and negative youth involvement in CBT was significantly associated with outcomes. Positive youth involvement during psychoeducation and exposure sessions predicted better outcomes, and negative youth involvement during psychoeducation sessions predicted less favorable outcomes. Sertraline did not moderate these findings. Therapist behaviors were not significantly associated with outcomes, likely due to limited variability and low frequency of observed behaviors. Youth in-sessions behaviors are associated with treatment outcomes in anxiety treatment. However, medication does not appear to have a differential impact on youth in-session behaviors. Keywords Anxious youth . CBT . Medication . Involvement
Cognitive behavioral therapy (CBT) is an efficacious treatment for youth with anxiety disorders (Hollon and Beck 2013) with long-term benefits (e.g., Swan et al. 2018; Wolk et al. 2015). Approximately 60% of youth have a positive response to CBT following a typical 16-week course of therapy (e.g., Kendall et al. 2008). However, approximately 20–
40% of youth are not rated as treatment responders (James et al. 2013). When CBT is combined with medication (i.e., selective serotonin reuptake inhibitors [SSRI]), treatment response rates increase to 80% (Walkup et al. 2008). There are investigations of why some youth do
Data Loading...
